ticides. Lastly, Iatropoulos (8) presented an accelerated rodent bioassay predictive of chemical carcinogenesis.
During the workshop, Dr. J. M. Faccini, who succeeded Dr. N. Ito as President, presented the IFSTP guidelines for the design and interpretation of the chronic rodent carcinogenicity bioassay. These guidelines were published separately as a special issue in the Journal of Experiinental and Toxicologic Pathology (4). Williams (19) demonstrated the advantages of classifying carcinogens as DNA-reactive and non-DNA-reactive, since the latter are capable of producing cancer only through disruption of cellular homeostasis. Swenberg (1 5 ) discussed the issue that almost all human carcinogens are genotoxic and that only half of rodent carcinogens are genotoxic. Hayashi (6) emphasized the usefulness of classifying environmental carcinogens into genotoxic and nongenotoxic and stressed the importance of studying the mechanisms of action of the nongenotoxic carcinogens.
Papers on Issues and Problems were presented duiing the second symposium. Enomoto (3) demonstrated how differences in species, sex, and individual nonneoplastic responses can help us with the rodent bioassay evaluation. Cohen (2) demonstrated how the production of calculi and microcrystals are instrumental in urothelial proliferation and carcinogenesis. Ward (17) reviewed the foci of hepatocellular alteration as proneoplastic markers useful in rodent hepatocarcinogenesis, even for nongenotoxic carcinogens. Lastly, Miyajima (1 2) reviewed the importance of considering spontaneous 102 lesions; artifacts; differences in species, strain, age, and sex; and reversibility of drug-related changes in assessing nephrotoxicity.
The majority of papers in the third symposium on Computerization dealt with new technology. Imaida et a1 (9) presented a three-dimensional analysis of altered hepatocellular foci in rodents utilizing a computer graphics system. Takahashi et a1 (16) applied computer-aided visualization to the morphogenesis of liver cirrhosis. Westen (1 8) demonstrated how digitized imaging in necropsy and histopathology can be effectively correlated, thus eliminating errors in transcription and translation. Huff (7) discussed scientific findings from rodent carcinogenicity bioassays and their implications for public health. Klopman (10) dealt with a very novel approach for predicting rodent carcinogenicity by utilizing artificial intelligence. Closing the symposium, Mohr and Morawietz (1 3) demonstrated the computerized rat tumor registry database, which exists in Hannover, Germany, as a joint project between the Hannover Medical School and the Fraunhofer Institute, with some 13 chemical and pharmaceutical companies in Germany and Switzerland.
The core issues of this first conference were the design and use of shorter chronic rodent bioassays and the advantages of a more scientific characterization of chemical carcinogens into those that are genotoxic and nongenotoxic. The potency of dose and effectiveness of exposure and the question of optimal duration of the experiment were thoroughly discussed. The consensus was that a more rational experimental design would be based on toxicokinetic and toxicodynamic considerations. The dose at the level of the biophase determines the response, whether a substance is genotoxic or nongenotoxic. The response starts when the threshold of dose has been crossed, or when the tissue capacity for adaptation has been surpassed, which is also a kind of threshold. Compound potency is fundamental for the dose threshold. The response threshold is determined by the cellular level of differentiation, its pattern ofadaptation to insult, and the way in which homeostasis is maintained by the three integrating systems (neural, endocrine, and immune). There is' a wide range of behavior for both thresholds, with the range of behavior of response threshold being by far the wider.
This was the most successful international meeting of toxicological pathologists to date, with 276 participants from 15 countries. All seven constituent societies of the IFSTP were represented, these being the British, Dutch, French, German-Swiss, Japanese, Nordic, and North American societies. Nagoya is a beautiful city. The Nagoya City Uni-versity Medical School Department of Pathology, under the organizational and scientific guidance of Dr. N. Ito, were superb hosts of a high-caliber scientific meeting. Much credit goes to Dr. Tomoyuki Shirai for the excellent local arrangements. The Japanese Society of Toxicologic Pathology, under the leadership of its president, Dr. Y. Nishiyama, provided a perfect framework for professionals to meet and to interact. Science and industrial R&D came together here to discuss the vital issues of safety assessment of chemical products. It is hoped that this trend of excellence will continue and become the hallmark of all future IFSTP meetings. 
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